Cancer Letters
Volume 316, Issue 2 , Pages 126-131 , 28 March 2012

Intussusceptive microvascular growth in tumors

  • Domenico Ribatti

      Affiliations

    • Department of Basic Medical Sciences, Section of Human Anatomy and Histology, University of Bari Medical School, 70124 Bari, Italy
    • Corresponding Author InformationCorresponding author. Address: Department of Basic Medical Sciences, Section of Human Anatomy and Histology, University of Bari Medical School, Piazza G. Cesare, 11, Policlinico, 70124 Bari, Italy. Tel.: +39 080 5478326; fax: +39 080 5478310.
    • ,
  • Valentin Djonov

      Affiliations

    • Institute of Anatomy, University of Berne Medical School, Berne, Switzerland

Received 19 September 2011 ,Revised 26 October 2011 ,Accepted 28 October 2011.

References 

  1. Ribatti D, Nico B, Crivellato E. Morphological and molecular aspects of physiological vascular morphogenesis. Angiogenesis. 2009;12:101–111
  2. Carmeliet P, Jain RK. Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases. Nat. Rev. Drug. Discovery. 2011;10:417–427
  3. Carmeliet P. Angiogenesis in life, disease and medicine. Nature. 2005;438:932–936
  4. Semenza GL. Targeting HIF-1 for cancer therapy. Nat. Rev. Cancer. 2003;3:721–732
  5. Ribatti D, Vacca A, Nico B, Roncali L, Dammacco F. Postnatal vasculogenesis. Mech. Dev. 2001;100:157–163
  6. Patan S, Alvarez MJ, Schittny JC, Burri PH. Intussusceptive microvascular growth: a common alternative to capillary sprouting. Arch. Histol. Cytol. 1992;55s:65–75
  7. Caduff JH, Fischer LC, Burri PH. Scanning electron microscopic study of the developing microvasculature in the postnatal rat lung. Anat. Rec. 1986;216:154–164
  8. Burri PH, Tarek MR. A novel mechanism of capillary growth in the rat pulmonary microcirculation. Anat. Rec. 1990;228:35–45
  9. Djonov V, Schnid M, Tschanz SA, Burri PH. Intussusceptive angiogenesis: its role in embryonic vascular network formation. Circ. Res. 2000;86:286–292
  10. Djonov V, Galli AB, Burri PH. Intussusceptive arborization contributes to vascular tube formation in the chick chorio-allantoic membrane. Anat. Embryol. 2000;202:347–357
  11. Djonov V, Kurz H, Burri PH. Optimality in the developing vascular system: branching remodeling by means of intussusception as an efficient adaptation mechanism. Dev. Dyn. 2002;224:391–402
  12. Djonov V, Baum O, Burri PH. Vascular remodeling by intussusceptive angiogenesis. Cell Tissue Res. 2003;314:107–117
  13. van Groningen JP, Wenink AC, Testers LH. Myocardial capillaries: increase in number by splitting of existing vessels. Anat. Embryol. 1991;184:65–70
  14. Zhou A, Eggington S, Hudlicka O, Brown MD. Internal division of capillaries in rat skeletal muscle in response to chronic vasodilator treatment with alpha1-antagonsit prazosin. Cell Tissue Res. 1998;293:293–303
  15. Hellstrom M, Kalen M, Lindahl P, Abramsson A, Betsholtz C. Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Development. 1999;126:3047–3055
  16. Wilting J, Birkenhager R, Eichmann A, Kurtz H, Martiny-Baron G, Marmé D, et al. VEGF121 induces proliferation of vascular endothelial cells and expression of flk-1 without affecting lymphatic vessels of chorioallantoic membrane. Dev. Biol. 1996;176:76–85
  17. Crivellato E, Nico B, Vacca A, Djonov V, Presta M, Ribatti D. Recombinant human erythropoietin induces intussusceptive microvascular growth in vivo. Leukemia. 2004;18:331–336
  18. Makanya AN, Hlushchuk R, Djonov V. Intussusceptive angiogenesis and its role in vascular morphogenesis, patterning, and remodeling. Angiogenesis. 2009;12:113–123
  19. Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O’Shea KS, et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature. 1996;380:439–442
  20. Suri C, Jones PF, Patan S, Bartunkova S, Maisonpierre PC, Davis S, et al. Requisite role of angiopoietin-1, a ligand for the Tie-2 receptor, during embryonic angiogenesis. Cell. 1996;87:1171–1180
  21. Machein MR, Knedla A, Knoth R, Wagner S, Neusche E, Plate KH. Angiopoietin-1 promotes tumor angiogenesis in a rat glioma model. Am. J. Pathol. 2004;165:1557–1570
  22. Ahmad SA, Liu W, Jumg YD, Fan F, Wilson M, Reinmuth H, et al. The effects of angiopoietin-1 and -2 on tumor growth and angiogenesis in human colon cancer. Cancer Res. 2001;61:1255–1259
  23. Stoeltzing O, Ahmad SA, Liu W, McCarty MF, Wey JS, Parikh AA, et al. Angiopoietin-1 inhibits vascular permeability, angiogenesis, and growth of hepatic colon cancer tumors. Cancer Res. 2003;63:3370–3377
  24. Thurston G. Complementary actions of VEGF and angiopoietin-1 on blood vessel growth and leakage. J. Anat. 2002;200:575–580
  25. Thurston G, Suri C, Smith K, Mc Cain J, Sato TN, Yancopoulos GD, et al. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science. 1999;286:2511–2514
  26. Folkman J. Role of angiogenesis in tumor growth and metastasis. J. Semin. Oncol. 2002;29(6 suppl. 16):15–18
  27. Ribatti D, Nico B, Crivellato E, Roccaro AM, Vacca A. The history of the angiogenic switch concept. Leukemia. 2007;21:44–52
  28. Ribatti D. The discovery of endothelial progenitor cells. An historical review. Leukemia Res. 2007;31:439–444
  29. Maniotis AJ, Folberg R, Hess AR, Seftor EA, Gardner LMG, Pe’er J, et al. Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am. J. Pathol. 1999;155:739–752
  30. Holash J, Maisonpierre PC, Compton D, Bolard P, Alexander CR, Zagzag D, et al. Vessel cooption, regression in tumors mediated by angiopoietins and VEGF. Science. 1999;284:1994–1998
  31. Patan S, Munn LL, Jain RK. Intussusceptive microvascular growth in a human colon adenocarcinoma xenograft: a novel mechanism of tumor angiogenesis. Microvasc. Res. 1996;51:260–272
  32. Djonov V, Hogger K, Sedlacek R, Laissue J, Draeger A. MMP-19: cellular localization of a novel metalloproteinase within normal breast tissue and mammary gland tumours. J. Pathol. 2001;195:147–155
  33. Crivellato E, Nico B, Vacca A, Ribatti D. B-cell non-Hodgkin’s lymphomas express heterogeneous patterns of neovascularization. Haematologica. 2003;88:671–678
  34. Ribatti D, Nico B, Floris C, Mangieri D, Piras F, Ennas MG, et al. Microvascular density, vascular endothelial growth factor immunoreactivity in tumor cells, vessel diameter and intussusceptive microvascular growth in primary melanoma. Oncol. Rep. 2005;14:81–84
  35. Nico B, Crivellato E, Guidolin D, Annese T, Longo V, Finato N, et al. Intussusceptive microvascular growth in human glioma. Clin. Exp. Med. 2010;10:93–98
  36. Paku S, Deszo K, Bugyik E, Tovari J, Timar J, Nagy P, et al. A new mechanism for pillar formation during tumor-induced intussusceptive angiogenesis. Inverse sprouting. Am. J. Pathol. 2011;179:1573–1585
  37. Drake CJ, Little CD. Exogenous vascular endothelial growth factor induces malformed and hyperfused vessels during embryonic neovascularization. Proc. Natl. Acad. Sci. USA. 1995;92:7657–7661
  38. Drake CJ, Little CD. VEGF and vascular fusion: implications for normal and pathological vessels. J. Histochem. Cytochem. 1999;74:1351–1355
  39. Baum O, Suter F, Gerber B, Schanz SA, Buergy R, Blank F, et al. VEGF-A promotes intussusceptive angiogenesis in the developing chicken chorioallantoic membrane. Microcirculation. 2010;17:447–457
  40. Williams JL, Cartland D, Rudge JS, Egginton S. VEGF trap abolishes shear stress and overload-dependent angiogenesis in skeletal muscle. Microcirculation. 2006;13:499–509
  41. Witmer AN, Dai J, Weich HA, Vrensen GF, Schlingemann RO. Expression of vascular endothelial growth factor receptors 1, 2, and 3 in quiescent endothelia. J. Histochem. Cytochem. 2002;50:767–777
  42. Ribatti D, Vacca A, Roccaro AM, Crivellato E, Presta M. Erythropoietin as an angiogenic factor. Eur. J. Clin. Invest. 2003;33:891–896
  43. Ribatti D, Presta M, Vacca A, Ria R, Giuliani R, Dell’Era P, et al. Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. Blood. 1999;93:2627–2636
  44. Ribatti D, Nico B, Perra MT, Longo V, Maxia C, Annese T, et al. Eryhtropoietin is involved in angiogenesis in human primary melanoma. Int. J. Exp. Pathol. 2010;91:495–499
  45. Nico B, Annese T, Guidolin D, Finato N, Crivellato E, Ribatti D. Epo is involved in angiogenesis in human glioma. J. Neuro-oncol. 2011;102:51–58
  46. Ribatti D, Nico B, Crivellato E, Vacca A. The structure of the vascular network of tumors. Cancer Lett. 2007;248:18–23
  47. Ribatti D. Vascular normalization: a real benefit ?. Cancer Chemother. Pharmacol. 2011;68:275–278
  48. Semela D, Piguet AC, Kolev M, Schmitter K, Hlushechuk R, Djonov V, et al. Vascular remodeling and antitumoral effects of mTOR inhibition in a rat model of hepatocellular carcinoma. J. Hepatol. 2007;46:840–848
  49. Hlushchuk R, Riesterer O, Baum O, Wood J, Gruber G, Pruschy M, et al. Tumor recovery by angiogenic switch from sprouting to intussusceptive angiogenesis after treatment with PTK787/ZK222584 or ionizing radiation. Am. J. Pathol. 2008;173:1173–1185
  50. Mancuso MR, Davis R, Norberg SM, O’Brien S, Sennino B, Nakahara T, et al. Rapid vascular regrowth in tumors after reversal of VEGF inhibition. J. Clin. Invest. 2006;116:2610–2621
  51. Drevs J, Muller-Driver R, Wittig C, Fuxius S, Esser N, Hugenschmidt H, et al. PTK787/ZK 222584, a specific vascular endothelial growth factor-receptor tyrosine kinase inhibitor, affects the anatomy of the tumor vascular bed and the functional vascular properties as detected by dynamic enhanced magnetic imaging. Cancer Res. 2002;62:4015–4022
  52. Rudin M, McSheehy PM, Allegrini PR, Rausch M, Baumann D, Becquet M, et al. PTK787/ZK222584, a tyrosine kinase inhibitor of vascular endothelial growth factor receptor, reduces uptake of the contrast agent GdDOTA by murine orthotopic B16/BL6 melanoma tumours and inhibits their growth in vivo. NMR Biomed. 2005;18:308–321
  53. Nakamura K, Yamamoto A, Kamishohara M, Takahashi K, Taguchi E, Miura T, et al. KRN633: a selective inhibitor of vascular endothelial growth factor receptor-2 tyrosine kinase that suppresses tumor angiogenesis and growth. Mol. Cancer Ther. 2004;3:1639–1649
  54. Nakamua K, Taguchi E, Miura T, Yamamoto A, Takahashi K, Bichat F, et al. KRN951, a highly potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, has antitumor actvities and affects vascular functional properties. Cancer Res. 2006;66:9134–9142
  55. Ruggeri B, Singh J, Gingrich D, Angeles T, Albom M, Yang S, et al. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models. Cancer Res. 2003;63:5978–5991
  56. Wnuk M, Hlushchuk R, Tuffin G, Huynh-Do U, Djonov V. The effects of PTK787/ZK222584, an inhibitor of VEGFR and PDGFRβ pathways, on intussusceptive angiogenesis and glomerular recovery from Thy1.1 nephritis. Am. J. Pathol. 2011;178:1899–1912
  57. Hlushchuk R, Makanya AN, Djonov V. Escape mechanism after antiangiogenic treatment, or why are the tumors growing again?. Int. J. Dev. Biol. 2011;55:563–567

PII: S0304-3835(11)00657-4

doi: 10.1016/j.canlet.2011.10.040

Cancer Letters
Volume 316, Issue 2 , Pages 126-131 , 28 March 2012

Article Tools

* Image Usage & Resolution